Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer
Clinical trial NCT04486287 · UNKNOWN
Trial details
- NCT number
- NCT04486287
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-09-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.